Chemokines in patients with ischaemic heart disease and the effect of coronary angioplasty

International Journal of Cardiology

Volumn 80, Issue 1, 2001, Pages 55-60

  Economou, Emanuel ^a   Tousoulis, Dimitris ^a   Katinioti, Anastasia ^a   Stefanadis, Christodoulos ^a   Trikas, Athanasios ^a   Pitsavos, Christos ^a   Tentolouris, Costas ^a   Toutouza, Marina G ^a   Toutouzas, Pavlos ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Angioplasty; Eotaxin; Inflammation; Monocyte

Indexed keywords

CHEMOATTRACTANT; EOTAXIN; MONOCYTE CHEMOTACTIC PROTEIN 1;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DILATATION; CORONARY ARTERY DISEASE; CYTOKINE RELEASE; EOSINOPHIL; FEMALE; HUMAN; INFLAMMATION; ISCHEMIC HEART DISEASE; MALE; MONOCYTE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TREATMENT OUTCOME;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CASE-CONTROL STUDIES; CHEMOKINE CCL2; CHEMOKINES, CC; CHEMOTACTIC FACTORS, EOSINOPHIL; CYTOKINES; FEMALE; HUMANS; INFLAMMATION; LINEAR MODELS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; STATISTICS, NONPARAMETRIC; UP-REGULATION;

EID: 0034862664     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(01)00454-5     Document Type: Article

References (34)

1. Atherosclerosis: A defence mechanism gone away
2. Novel inflammatory markers of coronary risk. Theory versus practice
3. Macrophages and atherosclerotic plaque stability
4. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol level
5. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
6. Induction of cytokine expression in leukocytes by binding of thrombin-stimulated platelets
7. Possible role of proinflammatory cytokines in heart allograft coronary artery disease
8. Atorvastatin reduces NF-kappa B, activation and chemokine expression in vascular smooth muscle cells and mononuclear cells
9. Activation of monocytes, T-lymphocytes and plasma inflammatory markers in angina patients
10. Cell proliferation in human coronary arteries
11. Plasma levels of the monocyte chemoattract protein-1 are elevated in patients with acute myocardial infarction
12. Macrophage colony-stimulating factor mRNA and protein in atherosclerotic lesions of rabbits and humans
13. Activated platelets induce monocyte chemotactic protein-1 secretion and surface expression of intercellular adhesion molecule-1 on endothelial cells
14. Monocyte chemoattract protein-1 in human atherosclerotic plaques
15. Eotaxin and eosinophil recruitment: Implications for human disease
16. Effects of reactive oxygen and nitrogen metabolites on eotaxin-induced eosinophil chemotactic activity in vitro
17. Eotaxin and capping protein in experimental vasculopathy
18. Restenosis after successful coronary angioplasty. Pathophysiology and prevention
19. Pre-angioplasty complicated coronary stenosis morphology as a predictor of restenosis
20. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions
21. Localized adhesion of monocytes to human atherosclerotic plaques demonstrated in vitro: Implications for atherogenesis
22. Cytokines regulate vascular function related to stability of the atherosclerotic plaque
23. Adhesion molecules and inflammatory injury
24. Intercellular adhesion molecule 1 (ICAM-1) has a central role in cell-cell contact-mediated immune mechanisms
25. Purification and amino acid analysis of two human glioma-derived monocyte chemoattractants
26. Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line
27. NF-kB and Sp1 regulate transcription of the human monocyte chemoattractant protein-1 gene
28. Expression of monocyte chemoattractant protein-1 in macrophage-rich areas of humans and rabbit atherosclerotic lesions
29. Detection of monocyte chemoattractant protein-1 in human atherosclerotic lesions by anti-monocyte chemoattractant protein-1 monoclonal antibody
30. Inhibition of NO synthesis induces inflammatory changes and monocyte chemoattractant protein-1 expression in rat hearts and vessels
31. Oxygen radicals as second messenger for expression of the monocyte chemoattractant protein, JE/MCP-1 and the monocyte colony-stimulating factor, CSF-1, in response to tumor necrosis factor and immunoglobulin: Evidence for involvement of reduced nicotinamide adeninine dinucleotide phosphate (NADPH)-dependent oxidase
32. Intracellular oxidative stress induced by nitric oxide synthesis inhibition increases endothelial cell adhesion to neutrophils
33. Nitric oxide decreases cytokine-induced endothelial activation: Nitric oxide selectively reduces endothelial expression of adhesion molecules and proiflammatory cytokines
34. The effects of eotaxin on the surface adhesion molecules of endothelial cells and on eosinophil adhesion to microvascular endothelial cells